Koninklijke DSM N.V.
KDSKF
Market Cap$723.89M
Close$
$65.72
39.2% downside
Current Fair Value
39.2% downsideOvervalued by 39.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $723.89 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $0.0 |
| Beta | 0.0 |
| Outstanding Shares | 6,696,477 |
| Avg 30 Day Volume | 39 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0.0 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Koninklijke DSM NV
CEO: Dimitri de Vreeze / Géraldine Matchett Koninklijke DSM NV engages in the manufacturing and sale of nutritional and pharmaceutical ingredients, and industrial chemicals. It operates through the following segments: Nutrition, Materials, and Innovation Center. The Nutrition segm...